首页> 外文OA文献 >PMC21 USING GROWTH IN THE COST-EFFECTIVENESS THRESHOLD TO INFORM THE DIFFERENTIAL BETWEEN THE DISCOUNT RATES ON COSTS AND HEALTH EFFECTS: REASON TO BE CAUTIOUS?

【2h】

PMC21 USING GROWTH IN THE COST-EFFECTIVENESS THRESHOLD TO INFORM THE DIFFERENTIAL BETWEEN THE DISCOUNT RATES ON COSTS AND HEALTH EFFECTS: REASON TO BE CAUTIOUS?

机译：PMC21使用成本效益的增长阈值通知差异的成本和健康效果之间的折扣率：理由要谨慎吗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J OMahony;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis [J] . Tjalke A. Westra, Mehraj B.Y. Parouty, Jan C. Wilschut, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012 ,第8期

机译：成本-效果分析中的成本和健康效应差异折现的实践意义
2. Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis [J] . James OMahony, Inge de Kok, Joost van Rosmalen, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012 ,第8期

机译：成本-效果分析中的成本和健康效应差异折现的实践意义
3. Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis [J] . Tjalke A. Westra, Mehraj B.Y. Parouty, Jan C. Wilschut, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012 ,第8期

机译：成本效益分析中成本折扣和健康效应的实际影响
4. Estimating cost of equity in project discount rates using the Capital Asset Pricing Model and Gordon's Wealth Growth Model [C] . A.S. Nhleko, C. Musingwini International Symposium on Mine Planning and Equipment Selection . 2015

机译：利用资本资产定价模型和戈登财富增长模型估算项目折扣率的股权成本
5. Modeling Health Preferences and Cost-Effectiveness of Current Breast Cancer Screening Technologies to Inform Policy, Practice, and Prevention Strategies. [D] . Decker-Palmer, Marquita. 2017

机译：对当前的乳腺癌筛查技术的健康偏好和成本效果进行建模，以告知政策，实践和预防策略。
6. Need for differential discounting of costs and health effects in cost effectiveness analyses [O] . Werner B F Brouwer, Louis W Niessen, Maarten J Postma, 2005

机译：在成本效益分析中需要对成本和健康影响进行不同的折现
7. Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis [O] . Westra, T.A., Parouty, M.B.Y., Wilschut, J.C., 2011

机译：成本效益分析中成本和健康影响差异贴现的实际意义
8. Selection of a discount rate for use in NRC regulatory analyses and application of discount rates to future averted health effects [R] . Paananen, O. H., Hendrickson, P. L. 1993

机译：选择用于NRC监管分析的贴现率以及贴现率对未来避免的健康影响的应用

PMC21 USING GROWTH IN THE COST-EFFECTIVENESS THRESHOLD TO INFORM THE DIFFERENTIAL BETWEEN THE DISCOUNT RATES ON COSTS AND HEALTH EFFECTS: REASON TO BE CAUTIOUS?

著录项

相似文献

相关主题

期刊订阅